EstechPharma Co Ltd banner
E

EstechPharma Co Ltd
KOSDAQ:041910

Watchlist Manager
EstechPharma Co Ltd
KOSDAQ:041910
Watchlist
Price: 8 190 KRW 30% Market Closed
Market Cap: ₩110.6B

EstechPharma Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

EstechPharma Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
E
EstechPharma Co Ltd
KOSDAQ:041910
Research & Development
-₩3B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
-2%
Yuhan Corp
KRX:000100
Research & Development
-₩197B
CAGR 3-Years
-19%
CAGR 5-Years
-10%
CAGR 10-Years
-19%
SK Biopharmaceuticals Co Ltd
KRX:326030
Research & Development
-₩162.2B
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Research & Development
-₩189.1B
CAGR 3-Years
-9%
CAGR 5-Years
4%
CAGR 10-Years
-1%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Research & Development
-₩8.7B
CAGR 3-Years
-8%
CAGR 5-Years
17%
CAGR 10-Years
-9%
C
Caregen Co Ltd
KOSDAQ:214370
Research & Development
-₩5.7B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

EstechPharma Co Ltd
Glance View

Market Cap
110.6B KRW
Industry
Pharmaceuticals

Estechpharma Co., Ltd. engages in the manufacture and supply of pharmaceutical ingredients and fine chemicals. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 162 full-time employees. The company went IPO on 2004-02-06. The Company’s products include remedies for alcoholism, anti-inflammatory, muscle relaxant, anti-septic, anti-spasmodic, anti-cataract, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, anti-histamine, anti-ulcerants, anti-rheumatics, anti-anemia, anti-diabetic, insecticide, anti-hypertensive, anti-asthmatic and anti-depressants, among others. The company has a research and development institute, which develops APIs. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
3 774.84 KRW
Overvaluation 54%
Intrinsic Value
Price
E

See Also

What is EstechPharma Co Ltd's Research & Development?
Research & Development
-3B KRW

Based on the financial report for Sep 30, 2025, EstechPharma Co Ltd's Research & Development amounts to -3B KRW.

What is EstechPharma Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-2%

Over the last year, the Research & Development growth was -2%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett